Clinical Trials
24 trialsNCT05867121 2026-04-27
A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010
Genentech, Inc.
Phase 1 Active not recruiting
NCT02454062 2024-09-04
A Trial of TAS-114 in Combination With S-1
Taiho Oncology, Inc.
Phase 1 Completed
NCT00400023 2024-09-03
A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors
Taiho Oncology, Inc.
Phase 1 Completed
NCT03162510 2022-04-07
SOLAR
National Health Research Institutes, Taiwan
Phase 1 Completed
NCT03380689 2021-03-08
SIRB2
Fujian Cancer Hospital
Phase 1 Withdrawn
NCT02862535 2020-12-24
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
Gilead Sciences
Phase 1 Terminated
NCT02347904 2019-11-18
SOX
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1 Completed
NCT02387138 2019-08-22
SIRINOX
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1 Completed
NCT03977220 2019-06-06
Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage â…¢ Gastric Cancer
Shanghai Zhongshan Hospital
Phase 1 Unknown
NCT02359058 2018-01-24
A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer
Eli Lilly and Company
Phase 1 Completed
NCT01713387 2017-10-09
A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Kansai Hepatobiliary Oncology Group
Phase 1 Completed
NCT03276156 2017-09-08
Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer
Zhejiang Cancer Hospital
Phase 1 Unknown
NCT01610479 2017-08-04
A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors
Taiho Pharmaceutical Co., Ltd.
Phase 1 Completed
NCT02867397 2016-08-15
Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors
Disphar International B.V.
Phase 1 Completed
NCT01693445 2016-02-19
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Hallym University Medical Center
Phase 1 Completed
NCT01128998 2015-10-19
Sorafenib Plus S-1 in Advanced Solid Tumors
National Health Research Institutes, Taiwan
Phase 1 Completed
NCT00553696 2015-03-13
Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer
Pfizer
Phase 1 Completed
NCT01291615 2014-10-23
Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Phase 1 Completed
NCT01291407 2013-09-18
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer
ChineseAMS
Phase 1 Completed
NCT01175447 2012-03-06
S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer
Zhejiang Cancer Hospital
Phase 1 Completed
NCT01175460 2012-03-06
S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer
Zhejiang Cancer Hospital
Phase 1 Completed
NCT00960349 2011-06-14
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients
AstraZeneca
Phase 1 Completed
NCT00479076 2011-01-26
A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
Sanofi
Phase 1 Completed
NCT00506207 2007-07-25
TIROX
National Cancer Center, Korea
Phase 1 Unknown